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Abstract Tamoxifen therapy for the treatment of hor-
mone responsive breast cancer has limitations due to
acquired resistance in the case of recurrences. Embelin, a
known inhibitor of X-linked inhibitor of apoptosis protein
(XIAP) was also reported to exhibit strong antiestrogenic
effects in animal models. Dual role of embelin as a proa-
poptotic and antiestrogenic agent may have potential ben-
efits in the therapy of breast cancer. In this study, the
effects of embelin treatment on estrogen receptor positive
Human breast adenocarcinoma (MCF-7) cells was inves-
tigated to primarily understand if embelin being an anti-
estrogen and XIAP inhibitor could be a potential
alternative to tamoxifen therapy. Results revealed that,
embelin at a concentration of 65 lg/ml attenuated prolif-
eration, inhibited metastatic migration, modulated the
expression of Bcl2, Caspases and induced apoptosis in
MCF-7 cells which was found to be p53 mediated. Hence,
chemotherapy with embelin could be a promising strategy
to be experimented in hormone responsive breast cancers.
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Introduction
Breast cancer is the most common malignancy in women
and despite the advances in diagnosis and treatment, it
presents the second leading cause of mortality due to
cancer in women worldwide [1]. Approximately 70 % of
breast cancers are estrogen receptor positive (ER?) and
mitogenic estrogen signaling plays a pivotal role in the
development and progression of ER? breast cancer [2].
Endocrine therapies, especially treatment with antiestro-
gens like tamoxifen is the recommended first line of che-
motherapy for ER? breast cancer. Antiestrogens act by
competitively binding to estrogen receptors on tumour cells
and hence blocking the effects of estrogen [3]. The major
setback in the treatment of breast cancer with antiestrogens
like tamoxifen is the unresponsiveness to therapy due to
acquired resistance or intrinsic insensitivity in case of
recurrences. Thus, the search is on for alternative anties-
trogenic compounds, which could be employed in the
chemotherapy of breast cancer.
Dysfunction of the apoptotic machinery is a funda-
mental characteristic of cancer that allows the transformed
cells to survive and proliferate. In part, this is due to defects
in the execution phase of apoptosis. The inhibitor of
apoptosis proteins (IAP) are one of the major protein
families that regulates Caspase activation and programmed
cell death. In particular, one of the IAP proteins, X-linked
inhibitor of apoptosis protein (XIAP) has been identified as
the most potent Caspase inhibitor to date [4]. XIAP is
expressed in almost all tissues and cell types. However, it is
often over expressed in tumours versus normal tissue [5, 6].
XIAP is capable of conferring resistance to cancer cells.
The benzoquinone and the small molecular inhibitor of
XIAP, embelin possess a wide spectrum of biological
activities with strong inhibition of NF-KB and down
K. R. Sumalatha  G. Abiramasundari  M. Sreepriya (&)
Department of Microbiology and Biotechnology, Bangalore
University, Jnana Bharathi Campus,
Bangalore 560056, Karnataka, India
e-mail: mpriya7@yahoo.com
G. K. Chetan
Department of Human Genetics, National Institute of Mental
Health and Neurosciences (NIMHANS),
Bangalore 560029, Karnataka, India
T. Divya  G. Sudhandiran
Department of Biochemistry, University of Madras, Guindy
Campus, Chennai 600023, Tamil Nadu, India
123
Mol Biol Rep (2014) 41:935–946
DOI 10.1007/s11033-013-2938-z
regulation of variety of gene products involved in tumour
cell survival, proliferation, invasion, angiogenesis and
inflammation [7]. The chemical structure of embelin has
resemblance with that of natural coenzyme Q10 (ubiqui-
nones) and the role of this is well defined in various bio-
chemical protective mechanisms [8]. Embelin is reported
as a potent oral contraceptive having 85.7 % antiimplan-
tation activity in female rats. It is also reported to inhibit
pregnancy and possess antiestrogenic and weak progesta-
tional activity [9–11]. The proapototic effects of embelin
coupled with its strong antiestrogenic effects suggest the
possibility of its potential therapeutic use in the chemo-
therapy of ER? breast cancer. Hence the objective of the
present study is to investigate the ability of embelin to
attenuate cell proliferation, inhibit metastasis and augment
apoptotic cell death in ER? human breast adenocarcinoma
cell line MCF-7. This is to understand the correlation
between the dual role of embelin as an apoptosis activator
and antiestrogenic compound, which was not previously
investigated. With increased resistance being reported to
antiestrogens like tamoxifen in case of recurrences, the
current study gains potential significance in addressing
clinical drug resistance in ER? breast cancer patients.
Materials and methods
Cell culture and reagents
In the study, a widely used ER? and estrogen dependent
MCF-7 cell line was employed as in vitro model system
and was procured from National Center for Cell Science
(NCCS), Pune, India. MCF-7 cells were cultured in sterile
ready to use Eagle’s Minimum Essential Medium (MEM,
AL075A, Himedia, India) supplemented with 19 Antibi-
otic Antimycotic solution (A007, Himedia, India) and
10 % Fetal Bovine Serum (FBS, RM1112, Himedia, India).
Cells were grown under standard growth conditions (tem-
perature 37 C, 5 % CO2 and 95 % humidity) in a CO2
incubator (Forma Scientific, USA). When a confluent
monolayer was formed, cells were detached with 0.25 %
Trypsin-0.2 % EDTA in Dulbecco’s phosphate buffered
saline (PBS) (T-001, Himedia, India) and then subcultured
at a split ratio of 1:3 in 12.5 cm2 volume tissue culture
flask (TCG2, Himedia, India). The media was changed
three times a week. The cells were grown in growth
medium containing 10 % FBS or maintained in mainte-
nance medium containing 5 % FBS. After arriving at
confluency, the cells were seeded onto 96 well microtitre
plates (TPP96, Himedia, India) and were utilized for var-
ious cell proliferation and cytotoxicity assays.
A stock solution of 5 mg/ml of embelin (Sigma, St.
Louis, MO, USA) was prepared in DMSO and stored as
small aliquots at -20 C. From the stock, appropriate
dilutions were carried out to prepare various concentrations
of embelin ranging from 1 to 100 lg/ml and used for the
following cytotoxicity and cell proliferation assays. In the
study, reference drug tamoxifen (Sigma, St. Louis, MO,
USA) was used at a concentration of 25 lg/ml [12].
Cell proliferation, cytotoxicity and antimetastatic
assays
Bromodeoxyuridine (BrdU) assay
Cell proliferation was measured by BrdU (5-bromo-20-
deoxyuridine) incorporation assay using a commercially
available kit (Calbiochem/Merck, Whitehouse Station, NJ,
USA) following the manufacturer’s recommendations.
Briefly, 10,000 cells/well were plated into 96 well plates in
the presence of embelin and BrdU label (1:2,000 dilution)
for 24 h. Plates were then washed, fixed with anti-BrdU
antibody, and peroxidase goat anti-mouse IgG conjugate.
Immunocomplex formation was measured using tetra-
methylbenzidine solution, and the reaction terminated
using 2.5 N sulfuric acid. The measured intensity is pro-
portional to the amount of incorporated BrdU in the cells.
Absorbance was measured at 450 nm.
MTT assay
MTT Assay was performed based on the protocol described
previously [13]. Briefly, a confluent flask was selected,
trypsinized and 5 9 106 cells/ml was cultured in 96 well
plate overnight and pretreated with various concentrations
of embelin and tamoxifen and allowed to proliferate for
72 h (temperature 37 C, 5 % CO2 and 95 % humidity).
25 ll of MTT (10 mg/ml in PBS) was added to the wells
and plates were incubated for 5–6 h. The formazan crystals
formed were solubilised by adding 75 ll of di-methyl
sulphoxide and the plate was read at 570 nm using a
microplate reader (Bio-Rad Laboratories, Hercules, CA,
USA). A dose response curve was constructed applying the
five parameter logistics using the Masterplex Readerfit:
Curve fitting software for ELISA analysis (Hitachi solu-
tions America, Ltd.). The concentration of embelin that
inhibited cell growth by 50 % (IC50) was calculated.
Trypan blue dye exclusion test
Trypan blue dye exclusion test was performed following
the method described previously [14]. After incubation
with embelin and tamoxifen for 24 and 48 h, cells were
harvested by trypsinization, washed with PBS, stained with
trypan blue (0.1 %) and the number of viable cells present
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was counted under an inverted phase contrast microscope
(Olympus, Japan) and the cell count was determined.
Clonogenic cell survival assay
A cell suspension (3 9 104 cells) in 4 ml of 0.4 % agar
with complete medium was overlaid on a 60 mm dish
containing 0.6 % agar base as described previously [15].
The media was changed two times a week and plates were
incubated at 37 C in a humidified incubator for 15 days.
The colonies formed in the untreated control and the
treated group were fixed with 3.7 % paraformaldehyde,
stained with crystal violet (0.1 %) and counted under a
light microscope (Olympus, Japan).
In vitro wound healing assay
Briefly, cells were seeded in a six well plate at a density of
5 9 104 cells/well, grown to near confluent monolayers in
10 % serum supplemented medium, and then starved
overnight in a low serum medium (0.5 % FBS). Wounds
were scratched (induced) through the cell monolayer using
a sterile 200 ll pipette tip as described previously [16]. The
cells were then washed twice very gently using PBS. PBS
was removed and replaced with 2 ml of media containing
test compounds and DMSO (0.1 %, v/v). After incubation
for 12–24 h in a humidified atmosphere at 37 C with 5 %
CO2, cells were fixed with 3.7 % formaldehyde and stained
with crystal violet (0.1 %). Each well was photographed
and the pictures were analyzed.
Assays to determine apoptotic cell death
Giemsa/crystal violet staining
Light microscopic analysis (treated and untreated cells)
was carried out after fixing the cells in Carnoy’s fixative
and subsequent staining with Giemsa/0.1 % crystal violet.
The morphology change in the untreated control and the
treated cells were observed (409 magnification) under a
trinocular inverted phase contrast microscope (Olympus,
Japan).
Hematoxylin–eosin staining
Cells after treatment were fixed in Carnoy’s fixative and
the morphology change in the untreated control and the
treated cells were analyzed by staining the cells with
hematoxylin and eosin. Cells were observed (1009 mag-
nification) under a light microscope (Olympus, Japan).
Acridine orange/ethidium bromide (AO/EB) staining
Dual staining with acridine orange and ethidium bromide
was performed based on the protocol previously described
[17]. Cells were seeded in six well plates for 24 h and
subjected to treatment with embelin and tamoxifen. After
incubation, cells were harvested by trypsinization and
washed with PBS, then stained with 0.1 mg/ml acridine
orange and 0.1 mg/ml ethidium bromide. Stained cell
suspension (10 ll) was placed on a clean glass slide and
covered with a cover slip. The cells were then observed
under a fluorescence microscope in both red channel
(590 nm) and green channel (520–550 nm) and the per-
centage of apoptosis was calculated.
Hoechst 33342 staining
Chromatin condensation was assessed by nuclear staining
with Hoechst 33342. After treatment with embelin and
tamoxifen for 24 h, cells were harvested, washed with PBS
thrice and then stained with 1 ll of Hoechst 33342 (5 mg/
ml). The suspension was incubated at 37 C in dark for
15 min. Stained cells were viewed and the images captured
Table 1 Sequence of primers
used in RT PCR
Sl. no. Gene Primer sequence Size of the product (bp)
1. XIAP F: 50AAGAGAAGATGACTTTTAACAG 30 575
R: 50 TGCTGAGTCTCCATATTGCC 30
2. p53 F: 50 CAGCCAAGTCTGTGACTTGCACGTAC30 293
R: 50CTATGTCGAAAAGTGTTTCTGTCATC 30
3. Bcl 2 F: 50 ACGATAACCGGGAGATAGTGATG 30 645
R: 50 CTGAGCAGAGTCTTCAGAGACA 30
4. Caspase 3 F: 50 CTTGGTAGATCGGCCATCTGAAAC 30 405
R: 50 GGTCCCGTACAGGTGTGCTTCGAC 30
5. Caspase 9 F: 50CAA AGG AGC AGA AAG TAG TGA AG 30 128
R: 50GAG GAA GGG CAG AAG TTC AC 30
6. b-Actin F: 50 AGATGACCCAGATCATGTTTGAGAC 30 720
R: 5 CTGATCCACATCTGCTGGAAGGT 30
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under a fluorescent microscope (Leica DM LB2, Japan)
using 350 nm extinction/stimulation and 460 nm emission.
Chromatin integrity in the untreated control and the treated
cells were analyzed.
Qualitative analysis of fragmented DNA
Cells (2 9 106/ml) were seeded in 25 cm2 tissue culture
flasks and allowed to attach overnight. Subsequently, cells
were treated with embelin and tamoxifen. After incubation,
cells were detached by trypsinisation, washed with PBS
and total DNA was extracted following the protocol
described previously [18] and loaded onto a 2 % agarose
gel in TAE buffer and run at 100 V for 30 min.
Quantitative determination of fragmented DNA
Quantitative determination of fragmented DNA was per-
formed using diphenylamine (DPA) as described previ-
ously [19]. Briefly, the procedure includes the lysis of cells
and release of nuclear DNA, a centrifugation step with the
generation of two fractions (corresponding to intact and
fragmented DNA, respectively), precipitation of DNA,
Fig. 1 Effect of embelin on proliferation of MCF-7 cells (MTT
assay)—pilot studies. It shows the effect of different concentrations of
embelin (15–70 lg/ml) on viability and proliferation of MCF-7 cells
as determined by MTT assay. Treatment of MCF-7 cells with
25–70 lg/ml showed statistically significant (P \ 0.001) decrease in
the proliferation of MCF-7 cells. Data represent mean ± SD of six
replicates. Intergroup comparisons were made between the cell
control and the treated groups. Student’s t test; ***P \ 0.001 and NS
non significant versus control
Fig. 2 Effect of tamoxifen and embelin on proliferation of MCF-7
cells (BrdU assay). It shows the effect of tamoxifen and embelin on
MCF-7 cells as determined by BrdU assay. Treatment with embelin
and tamoxifen resulted in a significant decrease in cell proliferation as
compared with the control. Data represent mean ± SD of six
replicates. Intergroup comparisons were made between the cell
control and the treated groups. Student’s t test; ***P \ 0.001
Fig. 3 Effect of tamoxifen and embelin on proliferation of MCF-7
cells (MTT assay). It shows the effect of tamoxifen and embelin on
MCF-7 cells as determined by MTT assay. Treatment with embelin
and tamoxifen resulted in a significant decrease in cell proliferation as
compared with the control. Data represent mean ± SD of six
replicates. Intergroup comparisons were made between the cell
control and the treated groups. Student’s t test; ***P \ 0.001
Fig. 4 Effect of tamoxifen and embelin on the growth of MCF-7
cells (Trypan Blue Dye Exclusion Test). It shows the effect of
tamoxifen and embelin on the growth of MCF-7 cells as assessed by
trypan blue dye exclusion test. Embelin and tamoxifen inhibited the
growth of MCF-7 cells in a time dependent manner. Cells treated with
embelin and tamoxifen for 24 and 48 h showed an appreciable
decrease in cell count as compared to control cells
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hydrolysis and colorimetric quantitation upon staining with
DPA at 600 nm using a microplate reader (Bio-Rad Lab-
oratories, Hercules, CA, USA).
TUNEL assay
DNA Strand breakage and fragmentation of the MCF-7
cells following treatment with embelin and tamoxifen was
ascertained by using the Fluorescein-FragELTMDNA
Fragmentation Detection Kit following the manufacturer’s
instructions. The assay is based on the principle that ter-
minal deoxynucleotidyl transferase (TdT) binds to exposed
3-OH ends of the DNA fragments generated in response to
apoptotic signals and catalyse the addition of fluorescein-
labeled and unlabeled deoxynucleotides. When excited,
fluorescein generates an intense signal that can be detected
by fluorescence microscopy and analyzed.
Comet assay
Single-cell gel electrophoresis (Comet assay) was per-
formed as described earlier [20]. It is a sensitive method to
visualize single strand breaks in nuclear DNA of cells.
Briefly, cells were cultured in 24-wells plates. After treat-
ment, cells were washed with 300 ll of PBS (pH 7.4), with
10 min of incubation at 37 C. Cells were detached by
incubation with 50 ll of trypsin (0.25 %) per well for
5 min, at 37 C. To decollate the cells, 300 ll of medium
containing 15 % fetal calf serum was added and pipetted
three to four times. Then, cells were lysed for 2 h and
transferred to fully frosted microscope slides (Menzel,
Bonn, Germany). After electrophoresis under alkaline
conditions (pH 13), DNA was stained with ethidium bro-
mide, and the slides were examined under a fluorescence
microscope (Leica DM LB2, Japan) and the results ana-
lysed using TriTek CometScoreTM 15 software. The extent
of DNA damage was expressed in terms of the percentage
of the tail DNA, head DNA and tail moment.
Reverse transcription PCR analysis
Total RNA from the treated and untreated control cells
were isolated using Trizol reagent. Oligo (dT)-primed
Fig. 5 Effect of tamoxifen and embelin on cloning efficiency and
surviving fraction. Colonies formed in soft agar after 15 days of
incubation were stained with 0.1 % crystal violet and photographed at
910 magnification. Data are representative of three independent
experiments. Magnification—910. Bar represents 10 lm
Table 2 Effects of tamoxifen and embelin on cloning efficiency and
surviving fraction—colony formation in soft agar
Sl.
no.
Groups No. of
colonies
Cloning
efficiency
Surviving
fraction
%
Survival
1. Control 38 0.76 – 100
2. Tamoxifen
treated
18 0.35 0.324 36.8
3. Embelin
treated
09 0.18 0.236 23.6
This table indicates the cloning efficiency and surviving fraction of
the cells treated with tamoxifen, embelin and untreated control. The
control cells showed a cloning efficiency of 0.76 as compared to a
cloning efficiency of 0.18 and 0.35 observed with the cells treated
with embelin and tamoxifen respectively. Decrease in the percentage
of survival was observed in the treated cells as compared to untreated
control
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RNA (1 lg) was reverse transcribed with MulMV reverse
transcriptase (Aristogene Biosciences Pvt Ltd., India). The
obtained cDNA was used to determine the expression of
XIAP, p53, Bcl 2, Caspase 3 and Caspase 9 using gene
specific primers. Primer sequences for the genes analysed
were listed in Table 1. b-Actin was used as the house
keeping gene. The PCR products were analysed on 1 %
agarose gels and densitometric analysis of the amplicons
were carried out using the ImageJ software. The density
values of the PCR products were normalized with the b-
actin product levels. Each PCR reaction was repeated at
least on three different occasions.
Statistical analysis
All the experiments were carried out in triplicate on at least
three different occasions and the mean of the replicate
values were taken. Values were expressed as mean ± SD.
Statistical analysis of the data was determined by Student’s
t test and comparisons were made between the untreated
control and treated groups.
Results
Pilot studies with embelin on MCF-7 cell line
Preliminary pilot studies (Fig. 1) were conducted with
various concentrations of embelin ranging from 1 to
100 lg/ml. The concentration of embelin which showed
maximum antiproliferative effect against the MCF-7 cell
line was determined. Treatment of MCF-7 cells with
1–15 lg/ml of embelin showed no influence on the pro-
liferation as compared to untreated control (data not
shown), whereas concentration between 25 and 70 lg/ml
showed statistically significant (P \ 0.001) decrease in the
proliferation of MCF-7cells. The concentration above
70 lg/ml that is 80–100 lg/ml (data not shown) showed no
appreciable decrease in the proliferation of cells when
compared to 70 lg/ml. Tamoxifen at a dose of 25 lg/ml
was used as mentioned before.
Effect of tamoxifen and embelin on proliferation
of MCF-7 cells
Results indicate that the cells treated with embelin showed
marked decrease in proliferation, which was found to be
statistically significant (P \ 0.001) as compared to control
(Figs. 2, 3). IC50 value of embelin was found to be 65 lg/
ml whereas the IC50 value of tamoxifen was reported to be
25 lg/ml. Hence this particular concentration of embelin
and tamoxifen which exhibited a marked influence on cell
proliferation was selected for all subsequent proliferation
and cytotoxicity studies. The IC50 values obtained for
embelin were in agreement with the reported IC50 values of
embelin on other carcinoma cell lines such as DLA
(370 lg/ml) and K-562 (114.5 lg/ml) respectively [21].
Effect of tamoxifen and embelin on growth of MCF-7
cells
Effect of tamoxifen and embelin on the growth inhibition
of MCF-7 cells was examined by trypan blue dye exclusion
Fig. 6 Effect of tamoxifen and embelin on cell migration and
invasion—antimetastatic activity. It shows the effect of tamoxifen and
embelin on the migration of MCF-7 cells as assessed by in vitro
wound healing assay. Wounds were induced by scratching and the
effects of embelin and tamoxifen on cell migration after the desired
incubation time was assessed by fixing the cells in formaldehyde and
later staining with crystal violet. Embelin and tamoxifen almost
completely clogged the migration of MCF-7 cells. Bar represents
10 lm
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test. The results showed that the viability of MCF-7 cells
was inhibited in a time dependent manner (Fig. 4). Cells
treated with embelin and tamoxifen for 24 and 48 h
showed a significant decrease in cell count as compared to
untreated control cells.
Effect of tamoxifen and embelin on cloning efficiency
and surviving fraction
Results revealed significant decrease in the number of
colonies (Fig. 5) and decrease in the percentage of survival
(Table 2) in the embelin treated group compared to that of
untreated control. Control cells showed a cloning efficiency
of 0.76 as compared to a cloning efficiency of 0.18
observed with the cells treated with embelin and 0.35
observed with the cells treated with tamoxifen.
Effect of tamoxifen and embelin on cell migration
and invasion-antimetastatic activity
As shown in Fig. 6 tamoxifen and embelin treatment
almost completely clogged the migration of MCF-7 cells.
The inhibition of migration was found to be more evident
in embelin treated cells, which demonstrated the antimet-
astatic potential of embelin.
Effect of tamoxifen and embelin on the morphology
of MCF-7 cells
Crystal violet/Giemsa staining
The presence of apoptotic bodies, cytoplasmic vacuoliza-
tion, cell shrinkage, formation of stretched nuclei,
Fig. 7 Effect of tamoxifen and embelin cell morphology—light
microscopy. It shows the effect of tamoxifen and embelin on the
morphology of MCF-7 cells after suitable staining. a Crystal violet
staining illustrate the appearance of apoptotic bodies, cytoplasmic
vacuolization, cell shrinkage, chromatin condensation and appearance
of micronuclei in embelin and tamoxifen treated cells and these were
not evident in the control cells. b GIEMSA staining revealed cell
shrinkage and nuclear fragmentations in embelin and tamoxifen
treated cells whereas the changes were not observed in the control
cells. c Hematoxylin–eosin staining revealed the appearance of
heterochromatic nuclei and decreased mitotic activity in embelin and
tamoxifen treated cells. Magnification: 9 49 10. Bar represents
40 lm
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proapoptotic nuclei manifested as chromatin condensation
at the periphery of the cell nucleus and appearance of
micronuclei (apoptotic nuclei) were seen after staining the
embelin and tamoxifen treated cells with crystal violet
(Fig. 7a). Giemsa staining showed that the cells exhibited
shrinkage and became smaller, the nuclei were broken, and
cell debris with nuclear fragmentations varying in shape
and size observed following embelin and tamoxifen
Fig. 8 Effect of tamoxifen and embelin on cell morphology—
fluorescence microscopy. It shows the effect of tamoxifen and
embelin on the morphology of MCF-7 cells as assessed by
fluorescence microscopy. a AO/EB staining revealed that cells
treated with tamoxifen and embelin showed a marked decrease in
the number of live cells compared to the untreated control. b Hoechst
33324 staining revealed chromatin condensation and nuclear frag-
mentation in the tamoxifen and embelin treated cells which were not
observed in untreated control. Bar represents 40 lm
Table 3 Percentage of apoptosis after AO/EB staining before and
after treatment with tamoxifen and embelin
Sl.
no.
Apoptosis Control Tamoxifen
treated
Embelin
treated
1. EA 5 ± 0.57 12 ± 1.52*** 17 ± 0.57***
2. LA 7 ± 1.51 22 ± 2.51*** 44 ± 2.51***
3. Total apoptotic
(TA)
13 ± 3.51 41 ± 2.51* 59 ± 5.77***
This table indicates the percentages of EA, LA and TA cells as
assessed by AO/EB staining. EA cells were visualized as green areas
with fragmented chromatin; LA dead cells were visualized as bright
orange cells with condensed chromatin. The live cells were visualized
as round and bright green cells. Data represent mean ± SD of six
replicates. Student’s t test; Intergroup comparisons were made
between treated and untreated groups
*** P \ 0.001; * P \ 0.05
Fig. 9 Effect of tamoxifen and embelin on DNA fragmentation—
agarose gel electrophoresis. It shows the qualitative assessment of the
effect of tamoxifen and embelin on DNA fragmentation. A typical
laddering pattern of DNA was observed in the treated cells which
were not observed in the untreated control cells. (M marker, C control,
T tamoxifen treated, E embelin treated)
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treatment (Fig. 7b). These features typical of apoptotic cell
death were not observed in the untreated control cells.
Haematoxylin and eosin staining
Apoptotic hallmarks manifested as high levels of cyto-
plasmic vacuolization and cell shrinkage was observed
after staining the cells with haematoxylin and eosin
(Fig. 7c).The appearance of heterochromatic nuclei and
decreased mitotic activity was observed in embelin and
tamoxifen treated cells whereas they were not evident in
the untreated control.
Effect of tamoxifen and embelin on chromatin integrity
of MCF-7 cells
Hoechst 33324 staining revealed the appearance of frag-
mented apoptotic nuclei and chromatin condensation after
treating with embelin and tamoxifen (Fig. 8a). Control
cells displayed the nuclei with malignant morphology
typical of MCF-7 cells while treated cells showed signifi-
cantly reduced apoptotic nuclei.
Effect of tamoxifen and embelin on morphology
of MCF-7 cells
Induction of apoptotic cell death was confirmed by mor-
phological observation of the cells after AO/EB staining.
As shown in Fig. 8b, the cells treated with embelin and
tamoxifen showed a marked decrease in the number of
live cells compared to the untreated control. Percentage of
total apoptosis before and after treatment with embelin is
represented in the Table 3. Compared with the sponta-
neous apoptosis observed in control MCF-7 cells [early
apoptotic (EA) 5 %; late apoptotic (LA) 7 %], Cells
treated with tamoxifen and embelin showed increased
percentages of EA (12 and 17 %), and LA cells (22 and
44 %), with concomitant increase in the total number of
apoptotic cells.
Effect of tamoxifen and embelin on DNA
fragmentation in MCF-7 cells
Laddering pattern on agarose gel
In order to investigate whether morphological changes
observed in the cells treated with tamoxifen and embelin
were in tandem with chromatin degradation patterns, aga-
rose gel electrophoresis of DNA extracted from cells
Table 4 Quantitative estimation of fragmented DNA by diphenyl
amine
Sl. no. Groups % of fragmented DNA
1. Control 16.1
2. Tamoxifen treated 52.6***
3. Embelin treated 76.2***
Data represent mean ± SD of six replicates. Student’s t test; inter-
group comparisons were made between the treated and the untreated
groups
*** P \ 0.001
Fig. 10 Effect of tamoxifen
and embelin on DNA damage—
TUNEL assay. a—C, T and
E indicate the control,
tamoxifen treated and embelin
treated MCF-7 cells.
Fluorescent intensity being
directly proportional to extent of
DNA damage. A graph
b showing the effect of embelin
and tamoxifen on MCF 7 cell
line. TUNEL positive cells were
counted and data are expressed
as mean ± SD. Apoptosis is
significantly induced by
embelin (P \ 0.001)
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treated with embelin were analyzed and a typical laddering
pattern of DNA was observed (Fig. 9).
Quantitative estimation of fragmented DNA
Statistically significant increase in the percentage of frag-
mented DNA was observed on treatment with tamoxifen
and embelin as compared to untreated control (Table 4).
Effect of tamoxifen and embelin on DNA damage—TUNEL
assay
Figure 10a depicts the results of the TUNEL assay and
subsequent fluorescence microscopic analysis of the con-
trol, embelin and tamoxifen treated MCF-7 cells. Fig-
ure 10b illustrates the number of TUNEL positive cells
observed in the control, embelin treated and tamoxifen
treated cells. Results indicate that embelin and tamoxifen
treated cells showed increased fluorescence and statisti-
cally significant increase in the number of TUNEL positive
cells (P \ 0.001) as compared to the untreated control.
This confirms the induction of DNA fragmentation and
apoptotic cell death following embelin and tamoxifen
treatment. More number of TUNEL positive cells were
observed in the embelin treated cells as compared to the
tamoxifen treated cells.
Effect of tamoxifen and embelin on DNA damage—Comet
assay
The results of the Comet assay (Fig. 11) ascertained
beyond doubt the induction of apoptotic cell death by
embelin and tamoxifen. Results showed that embelin and
tamoxifen treated cells exhibited DNA damage as evi-
denced by increase in the percentage of tail DNA, decrease
in the percentage of head DNA and increased tail moment
as compared to the untreated control which was found to be
statistically significant (P \ 0.001) .
Effect of tamoxifen and embelin on the expression
of Caspase 3, Caspase 9, Bcl2, XIAP and p53
Decreased expression of XIAP, Bcl-2 and increased
expression of p53, Caspase 3 and Caspase 9 was observed
in the tamoxifen and embelin treated cells as compared to
that of untreated control (Fig. 12a). Results of densito-
metric analysis and the difference in relative densities of
the bands in different groups were illustrated in Fig. 12b.
Discussion
Cell proliferation is a culmination of a cascade of bio-
chemical events which is mediated by several transcription
Fig. 11 Effect of tamoxifen and embelin on DNA damage—Comet assay. Appearance of Comet enabled the determination of major
measurement parameters, including % DNA in head, % of DNA in the tail and Olive moment
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factors, cell signaling molecules and enzymes. The various
assays performed to understand the effects of embelin on
the cellular redox status, metabolic activity and clonogenic
potential confirmed its cytotoxic and antiproliferative
effects on human breast adenocarcinoma cell line MCF-7,
which was found to be comparable to that of tamoxifen. In
addition to this it was also observed that embelin and
tamoxifen treatment clogged the migration of MCF-7 cells
and exhibited marked inhibitory effects on cell migration.
Cell migration is an important index of metastatic potential
and a preliminary idea about the antimetastatic potential of
test compounds could be revealed in vitro by the wound
healing assay which involves complex and orderly
sequence of events involving cell migration and prolifera-
tion [22]. In the current study, the antiinvasive potential as
shown by the results of the scratch assay was found to be
more evident in embelin treated cells compared to
tamoxifen treated cells.
The fact that embelin exerted significant antiprolifera-
tive and antiinvasive effects, stimulated the interest to
investigate whether the effect is mediated via apoptotic
cascade, as induction of apoptosis is known to be a
promising strategy for cancer prevention. A key regulator
of apoptosis is the proapoptotic p53 tumour suppressor
protein, which controls cell cycle progression and DNA
repair [23]. p53 induces apoptosis by regulating the
expression of proteins like Bcl2 and Bax. This concomi-
tantly induces cytochrome C release and activates Caspase
cascade (primarily Caspase 9 and Caspase 3) leading to
apoptosis [24]. As any alteration in the expression of these
proteins can be pivotal in the onset of oncogenesis, it was
intended to study the modulation of XIAP, p53, Bcl2,
Caspase 9 and Caspase 3 expressions under tamoxifen and
embelin treatment on ER? MCF-7 cell line. The results of
RT-PCR analysis implicated that embelin induced an
upregulation in the expression of p53, Caspases and down
regulation in the expression of Bcl2, XIAP thereby
inducing apoptotic cell death in MCF-7 cell line. This
could be due to the strong inhibitory effects of embelin on
the activation NF-KB [7, 25].
Interestingly, one of the mechanisms by which breast
cancer patients develop resistance to tamoxifen therapy is
through the activation of NF-KB. Hence, NF-KB inhibition
coupled with potent antiestrogenic effects could enable
embelin to antagonize E2 in an ER dependent manner to
synergistically downregulate antiapoptotic genes and pro-
mote apoptotic cell death. Induction of apoptotic cell death
upon embelin treatment was further confirmed by
Fig. 12 Effect of tamoxifen and embelin on the expression of
Caspase 3, Caspase 9, Bcl 2, XIAP, p53—reverse transcription PCR
(M marker, C control, T tamoxifen treated, E embelin treated).
Decreased expression of XIAP, Bcl-2 and increased expression of
p53, Caspase-3 and Caspase-9 (a) was observed in tamoxifen and
embelin treated cells as compared to that of untreated control. The
relative densities as analysed from ImageJ software is as shown in b
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morphological changes in the cell as observed by light
microscopy and fluorescence microscopy analysis.
To conclude, we report for the first time the antiprolif-
erative, antimetastatic and proapoptotic effects of embelin
which is p53 mediated on ER? breast cancer cell line
MCF-7. With a sizable proportion of breast cancer patients
becoming resistant to tamoxifen therapy, alternative ther-
apeutic strategies to treat hormone responsive breast cancer
by employing compounds like embelin which has a dual
role as antiestrogen/XIAP inhibitor opens up interesting
avenues for study.
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